Inhaled Dual PDE3/4 Inhibitor Ensifentrine for Chronic Obstructive Pulmonary Disease: A Potential Therapeutic Perspective

Am J Respir Crit Care Med. 2024 Jan 15;209(2):223-224. doi: 10.1164/rccm.202307-1143LE.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Inhalation
  • Adrenal Cortex Hormones / therapeutic use
  • Asthma* / drug therapy
  • Bronchodilator Agents / therapeutic use
  • Humans
  • Isoquinolines / pharmacology
  • Isoquinolines / therapeutic use
  • Phosphodiesterase 3 Inhibitors / pharmacology
  • Phosphodiesterase 3 Inhibitors / therapeutic use
  • Pulmonary Disease, Chronic Obstructive* / drug therapy
  • Pyrimidinones*

Substances

  • Phosphodiesterase 3 Inhibitors
  • ensifentrine
  • Isoquinolines
  • Bronchodilator Agents
  • Adrenal Cortex Hormones
  • Pyrimidinones